NSCLC immunization ‘proof of concept’ achieved
Immunization against MAGE-A3 is a feasible adjuvant treatment in patients with resectable non-small-cell lung cancer expressing the tumor-specific antigen, research suggests.
Source: MedWire News - Lung Cancer - Category: Cancer & Oncology Source Type: news